|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
JP2014524472A
(ja)
*
|
2011-08-22 |
2014-09-22 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｂａｃｅ阻害剤としての２−スピロ置換イミノチアジンならびにそのモノオキシドおよびジオキシド、組成物、ならびにそれらの使用
|
|
NZ702254A
(en)
*
|
2012-05-24 |
2016-08-26 |
Hoffmann La Roche |
5-amino[1,4]thiazines as bace 1 inhibitors
|
|
US9556135B2
(en)
|
2012-10-12 |
2017-01-31 |
Amgen, Inc. |
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
|
WO2014093190A1
(en)
|
2012-12-14 |
2014-06-19 |
Merck Sharp & Dohme Corp. |
Bace inhibitors of iminothiadiazine dioxides
|
|
AU2013363151A1
(en)
*
|
2012-12-20 |
2015-06-04 |
Merck Sharp & Dohme Corp. |
C5, C6 oxacyclic-fused iminothiazine dioxide compounds as BACE inhibitors
|
|
US9580396B2
(en)
|
2012-12-21 |
2017-02-28 |
Merck Sharp & Dohme Corp. |
C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
|
|
WO2014120658A1
(en)
|
2013-01-29 |
2014-08-07 |
Amgen Inc. |
Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
|
|
MX366855B
(es)
|
2013-03-01 |
2019-07-26 |
Amgen Inc |
Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso.
|
|
CN105164121A
(zh)
|
2013-03-08 |
2015-12-16 |
美国安进公司 |
作为β分泌酶抑制剂的全氟化环丙基稠合的1,3-噁嗪-2-胺化合物以及其使用方法
|
|
EP2968353B1
(en)
*
|
2013-03-15 |
2018-12-19 |
Merck Sharp & Dohme Corp. |
C2-azaspiro iminothiazine dioxides as bace inhibitors
|
|
WO2014150340A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiadiazine compounds as bace inhibitors, compositions, and their use
|
|
EP2968357B1
(en)
*
|
2013-03-15 |
2018-07-04 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
|
EP3083575B1
(en)
*
|
2013-12-18 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
EP3082823B1
(en)
*
|
2013-12-18 |
2020-04-22 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2918171A1
(en)
*
|
2014-03-14 |
2015-09-16 |
University of Vienna |
Novel plant growth regulators and their use in modulating organ number
|
|
KR20180078347A
(ko)
|
2014-04-10 |
2018-07-09 |
화이자 인코포레이티드 |
2-아미노-6-메틸-4,4a,5,6-테트라히드로피라노[3,4-d][1,3]티아진-8a(8H)-일-1,3-티아졸-4-일 아미드
|
|
US9732088B2
(en)
|
2014-06-02 |
2017-08-15 |
Merck Sharp & Dohme Corp. |
C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
|
|
US10047102B2
(en)
|
2014-07-25 |
2018-08-14 |
Hoffmann-La Roche Inc. |
Pyridyl-triazabicycles
|
|
EP3191447B1
(en)
|
2014-09-12 |
2019-05-01 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
EP3261442B1
(en)
|
2015-01-20 |
2020-04-01 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
|
|
MX2017012188A
(es)
|
2015-03-20 |
2017-12-15 |
Hoffmann La Roche |
Inhibidores de beta-secretasa 1 (bace1).
|
|
JP6765681B2
(ja)
*
|
2015-04-21 |
2020-10-07 |
オールジェネシス バイオセラピューティクス インコーポレイテッド |
Ｂａｃｅ１阻害剤としての化合物およびそれらの使用
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
EP3353183A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
|
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
|
CA3005727A1
(en)
|
2015-11-19 |
2017-05-26 |
Incyte Corporation |
Substituted 2-methylbiphenyl-3-yl heterocyclic compounds and pharmaceutical compositions thereof useful as immunomodulators
|
|
WO2017095759A1
(en)
|
2015-12-04 |
2017-06-08 |
Merck Sharp & Dohme Corp. |
C5-c6-carbocyclic fused iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
TW201726623A
(zh)
*
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
|
CR20180374A
(es)
|
2015-12-22 |
2018-10-16 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
MA44860A
(fr)
|
2016-05-06 |
2019-03-13 |
Incyte Holdings Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
US20170342060A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CA3028685A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018013789A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2941716T3
(es)
|
2016-08-29 |
2023-05-25 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
US11021493B2
(en)
|
2016-12-15 |
2021-06-01 |
Amgen Inc. |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
JP7148518B2
(ja)
|
2016-12-15 |
2022-10-05 |
アムジエン・インコーポレーテツド |
β－セクレターゼ阻害剤としての二環式チアジンおよびオキサジン誘導体ならびに使用方法
|
|
AU2017378316B2
(en)
|
2016-12-15 |
2021-04-01 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
CA3047288A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
JP7303108B2
(ja)
|
2016-12-22 |
2023-07-04 |
インサイト・コーポレイション |
免疫調節剤としての二環式複素芳香環化合物
|
|
CR20190318A
(es)
|
2016-12-22 |
2019-10-21 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
SG10202106743QA
(en)
|
2016-12-22 |
2021-08-30 |
Incyte Corp |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2899402T3
(es)
|
2016-12-22 |
2022-03-11 |
Incyte Corp |
Derivados de piridina como inmunomoduladores
|
|
KR102717600B1
(ko)
|
2017-10-06 |
2024-10-15 |
포르마 세라퓨틱스 인크. |
유비퀴틴 특이적 펩티다제 30의 억제
|
|
CN111511732A
(zh)
*
|
2017-12-21 |
2020-08-07 |
豪夫迈·罗氏有限公司 |
放射性标记化合物
|
|
JP7590183B2
(ja)
|
2018-03-13 |
2024-11-26 |
武田薬品工業株式会社 |
血漿カリクレインのインヒビターとしての置換されたイミダゾピリジン及びその使用
|
|
EP4212529B1
(en)
|
2018-03-30 |
2025-01-29 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
BR112020021728A2
(pt)
|
2018-04-27 |
2021-01-26 |
Shionogi & Co., Ltd. |
derivados de tetra-hidropiranooxazina tendo atividade inibitória de bace1 seletiva
|
|
EP4520328A3
(en)
|
2018-05-11 |
2025-04-16 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CA3098628A1
(en)
|
2018-05-17 |
2019-11-21 |
Forma Therapeutics, Inc. |
Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
|
|
CN108997328B
(zh)
*
|
2018-09-06 |
2021-06-08 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
PT3860989T
(pt)
|
2018-10-05 |
2023-06-30 |
Forma Therapeutics Inc |
Pirrolinas fundidas que atuam como inibidores da protease 30 específica da ubiquitina (usp30)
|
|
WO2021030162A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
|
CN114258392A
(zh)
*
|
2019-08-21 |
2022-03-29 |
卡尔维斯塔制药有限公司 |
酶抑制剂
|
|
WO2021055589A1
(en)
|
2019-09-18 |
2021-03-25 |
Shire Human Genetic Therapies, Inc. |
Heteroaryl plasma kallikrein inhibitors
|
|
WO2021055621A1
(en)
|
2019-09-18 |
2021-03-25 |
Shire Human Genetic Therapies, Inc. |
Plasma kallikrein inhibitors and uses thereof
|
|
CR20220190A
(es)
|
2019-09-30 |
2022-06-15 |
Incyte Corp |
Compuestos de pirido [3,2-d] primidina como inmunomoduladores
|
|
EP4058461A1
(en)
|
2019-11-11 |
2022-09-21 |
Incyte Corporation |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
|
PE20231438A1
(es)
|
2020-11-06 |
2023-09-14 |
Incyte Corp |
Proceso para hacer un inhibidor de pd-1/pd-l1 y sales y formas cristalinas del mismo
|
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
|
CA3256688A1
(en)
|
2022-04-28 |
2025-04-22 |
Kyoto Pharmaceutical Industries, Ltd. |
BENZOTRIAZOLE COMPOUND
|